Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | 0.00% |
|
-11.11% | +9.09% |
08:05am | PYC Therapeutics Advances Trial for Drug Candidate; Shares Up 4% | MT |
06-18 | Canaccord Genuity Starts PYC Therapeutics at Buy With AU$0.22 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.09% | 374M | |
+17.95% | 45.51B | |
-8.70% | 38.52B | |
+38.08% | 38.13B | |
+27.06% | 30.74B | |
-8.64% | 26.03B | |
+12.82% | 25.92B | |
+47.62% | 14.13B | |
+34.84% | 12.73B | |
-6.93% | 11.29B |
- Stock Market
- Equities
- PYC Stock
- News PYC Therapeutics Limited
- PYC Therapeutics Receives AU$4.5 Million Upfront Fee for Drug Discovery Collaboration